Maxivision Sets Sights on Tamil Nadu with ₹400 Crore Investment

Maxivision Super Speciality Eye Hospitals is set to invest approximately ₹400 crore in Tamil Nadu over the next 2–3 years, marking a major expansion into the state. Of this, ₹100 crore will be dedicated to establishing a network of 10 super speciality eye hospitals and vision centers in Chennai alone.

Dr. GSK Velu, Chairman and Managing Director of Maxivision, shared that the company—having raised ₹1,300 crore from private equity firm Quadria Capital in 2023—is preparing for an IPO in 2027. He noted that Maxivision is currently the third-largest eye care chain in India by revenue and the second-largest by profit, with an annual revenue of around ₹700 crore.

Explaining the rationale behind the timing, Dr. Velu said, “For a city like Chennai, just one hospital will not be impactful. So we were waiting for adequate funding to cover Chennai city well with our network.” He emphasized that Chennai, despite its size, remains an underpenetrated market with significant growth potential.

Founded in 1996 by Dr. Kasu Prasad Reddy and acquired by Dr. Velu in 2011, Maxivision has primarily focused on expanding its footprint across Andhra Pradesh, Telangana, Gujarat, and Maharashtra since 2012.

News by Rahul Yelligetti.